CRISPR approval could rearrange the health market
The Future. The first treatment using the gene-editing tech CRISPR has already been approved in the US and UK for patients suffering from sickle cell disease. There are still a lot of kinks to work out concerning costs and patient safety in the broader market, but the health industry may be close to having treatments […]
